Huron Consulting Group (NASDAQ:HURN) Updates FY 2025 Earnings Guidance

Huron Consulting Group (NASDAQ:HURN) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 6.800-7.600 for the period, compared to the consensus estimate of 7.160. The company issued revenue guidance of $1.6 billion-$1.7 billion, compared to the consensus revenue estimate of $1.6 billion.

Huron Consulting Group Trading Down 0.6 %

Huron Consulting Group stock opened at $142.38 on Wednesday. The stock has a 50-day simple moving average of $140.33 and a 200 day simple moving average of $126.94. The stock has a market capitalization of $2.55 billion, a P/E ratio of 30.95 and a beta of 0.37. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.61 and a current ratio of 1.61. Huron Consulting Group has a 52 week low of $84.26 and a 52 week high of $153.85.

Huron Consulting Group (NASDAQ:HURN) last issued its earnings results on Tuesday, February 25th. The business services provider reported $1.90 EPS for the quarter, topping the consensus estimate of $1.52 by $0.38. Huron Consulting Group had a return on equity of 21.51% and a net margin of 5.80%. The company had revenue of $399.31 million during the quarter, compared to the consensus estimate of $380.62 million. Analysts expect that Huron Consulting Group will post 6.1 earnings per share for the current year.

Analysts Set New Price Targets

HURN has been the subject of a number of research reports. Wedbush raised their target price on shares of Huron Consulting Group from $150.00 to $165.00 and gave the stock an “outperform” rating in a research note on Wednesday, March 26th. Benchmark restated a “buy” rating and set a $165.00 price objective on shares of Huron Consulting Group in a report on Wednesday, March 26th. William Blair reissued an “outperform” rating on shares of Huron Consulting Group in a report on Wednesday, March 26th. Truist Financial increased their price objective on Huron Consulting Group from $165.00 to $180.00 and gave the stock a “buy” rating in a research report on Tuesday, March 4th. Finally, Barrington Research restated an “outperform” rating and issued a $167.00 price target on shares of Huron Consulting Group in a research note on Thursday, March 27th. Six equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $169.25.

Insider Transactions at Huron Consulting Group

In other Huron Consulting Group news, Director John Mccartney sold 500 shares of the firm’s stock in a transaction dated Tuesday, April 1st. The shares were sold at an average price of $142.67, for a total value of $71,335.00. Following the transaction, the director now directly owns 52,121 shares of the company’s stock, valued at $7,436,103.07. This trade represents a 0.95 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO C. Mark Hussey sold 27,672 shares of the company’s stock in a transaction that occurred on Tuesday, March 4th. The stock was sold at an average price of $145.91, for a total transaction of $4,037,621.52. Following the sale, the chief executive officer now directly owns 81,118 shares of the company’s stock, valued at approximately $11,835,927.38. This trade represents a 25.44 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 78,781 shares of company stock valued at $11,484,452. 2.02% of the stock is owned by corporate insiders.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.